“…Ubiquitin deposition has been observed in neurofibrillary tangles of AD, Lewy bodies of Parkinson's disease, and Bunina bodies of amyotrophic lateral sclerosis (ALS), as well as nuclear inclusions in Huntington's disease, spinocerebellar ataxias, and Kennedy's disease (46). Many proteins involved in AD pathogenesis, including tau (47,48), the APP C terminus (49 -51), BACE1 (31), PS1 (52-54), PS2 (55), Nct-1 (56), Pen-2 (57, 58), Aph-1 (59,60), and TMP21 (61), are degraded by ubiquitin-proteasome pathways. Our work and other studies have demonstrated that RCAN1 can be ubiquitinated and that inhibition of proteasome markedly increases RCAN1 levels (29,62,63).…”